Maia Pharms

Maia Pharmaceuticals is a specialty pharmaceutical company based in Princeton, New Jersey, focused on the development and commercialization of high-barrier-to-entry generic and branded pharmaceutical products. The company specializes in complex formulations, particularly injectable and ophthalmic dosage forms, utilizing the FDA's 505(b)(2) and 505(j) regulatory pathways. Maia's portfolio includes several essential hospital medicines such as Nitroprusside Sodium, Pantoprazole Sodium, and Bivalirudin, targeting therapeutic areas like oncology, critical care, and cardiovascular health. By employing a lean, virtual business model and collaborating with global manufacturing partners, Maia aims to provide high-quality, cost-effective alternatives to critical care medications. The company is led by an experienced management team with a track record in the specialty and generic pharmaceutical industries.